Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
579232
Reference Type
Journal Article
Title
Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation
Author(s)
Pawlyk, AC; Cosmi, S; Alfinito, PD; Maswood, N; Deecher, DC
Year
2006
Is Peer Reviewed?
Yes
Journal
Brain Research
ISSN:
0006-8993
EISSN:
1872-6240
Volume
1123
Issue
1
Page Numbers
135-144
Language
English
PMID
17067560
DOI
10.1016/j.brainres.2006.09.050
Abstract
Thermoregulation is a complex intercommunicative function requiring coordination between core body temperature (CBT), the central nervous system, and peripheral vasculature. In menopausal women, dysregulation of thermoregulatory mechanisms leads to hot flushes and night sweats. A previous study in ovariectomized (OVX) rats has suggested that mirtazapine can alleviate thermoregulatory dysfunction by blocking 5-HT2A receptor signaling. This is in opposition to other work in which 5-HT2A receptor blockade appeared to exacerbate thermoregulatory dysfunction in OVX rats. Thus, the goals of the present study were to reexamine the effects of mirtazapine on temperature regulation in OVX rat models and explore further the role of 5-HT2A receptor blockade. Mirtazapine exhibited potent functional antagonism (EC50 = 0.62 nM) at the cloned human 5-HT2A receptor. In the morphine-dependent model of thermoregulatory dysfunction, mirtazapine (10 mg/kg, i.p.) induced an increase in tail-skin temperature (TST) prior to naloxone administration. In the telemetry model, mirtazapine (0.3-3 mg/kg, i.p.) caused an increase in TST. However, at the highest dose tested (10 mg/kg, i.p.), mirtazapine induced a small but significant decrease in TST followed by an increase in TST. To examine this finding further, mirtazapine's effect on CBT was determined. Administration of mirtazapine (1-3 mg/kg, i.p.) resulted in a slight decrease in CBT but at the 10 mg/kg dose a dramatic decrease (- 3.6 °C) in CBT was observed. These data support the concept that 5-HT2A receptors play a role in temperature regulation but that functional blockade of these receptors by mirtazapine is not a likely mechanism for restoring thermoregulatory processes in OVX rats.
Keywords
Thermoregulation; Vasomotor symptom; 5-HT2A receptor; Hot flush; Rat model; Mirtazapine
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity